Skip to content
  • Solutions
    • DFdiscover CDMS
    • DFengage ePRO
    • DFcollect
    • DFconsent
    • Services
  • Industries
    • Biotech & Pharma
    • CROs
    • Medical Devices
    • Research Organization
  • Partners
  • Resources
    • Knowledge Hub
    • Blog
      • Thought Leadership
      • Announcements/PR
    • Customer Success
    • User Community
  • About
    • Careers
  • Contact Us
  • My Account
  • My Account
    • Software Releases
    • Log out
Menu
  • Solutions
    • DFdiscover CDMS
    • DFengage ePRO
    • DFcollect
    • DFconsent
    • Services
  • Industries
    • Biotech & Pharma
    • CROs
    • Medical Devices
    • Research Organization
  • Partners
  • Resources
    • Knowledge Hub
    • Blog
      • Thought Leadership
      • Announcements/PR
    • Customer Success
    • User Community
  • About
    • Careers
  • Contact Us
  • My Account
  • My Account
    • Software Releases
    • Log out
  • Solutions
    • DFdiscover CDMS
    • DFengage ePRO
    • DFcollect
    • DFconsent
    • Services
  • Industries
    • Biotech & Pharma
    • CROs
    • Medical Devices
    • Research Organization
  • Partners
  • Resources
    • Knowledge Hub
    • Blog
    • Customer Success
    • User Community
  • About Us
    • Careers
Menu
  • Solutions
    • DFdiscover CDMS
    • DFengage ePRO
    • DFcollect
    • DFconsent
    • Services
  • Industries
    • Biotech & Pharma
    • CROs
    • Medical Devices
    • Research Organization
  • Partners
  • Resources
    • Knowledge Hub
    • Blog
    • Customer Success
    • User Community
  • About Us
    • Careers
  • Contact Us
  • My Account
  • Contact Us
Menu
  • Contact Us
Schedule a Demo
Blog

HPTN 074 Demonstrates Significant Benefits Among People Living with HIV Who Inject Drugs

  • Published by Eric Bosch
  • Posted at September 5, 2018

More terrific, breaking news from our friends at the HIV Prevention Trials Network. We've had the pleasure of providing data management support for the HPTN 074 trial since January 2015. Congratulations to the investigators and study team.

From the press release: "Investigators from the HIV Prevention Trials Network (HPTN) today announced The Lancet has published key results from HPTN 074. At 52 weeks from enrollment, participants in the intervention arm nearly doubled their antiretroviral therapy usage, viral suppression and medication-assisted treatment usage compared to the standard of care arm. Mortality was also reduced by more than half with the intervention."

Read the full press release on the HPTN website.

Previous

FDA Approves the First One-Year Contraceptive Fully under a Woman’s Control
Next

Reflections on DFUG 2018
DFnet is a healthcare technology company that provides eClinical solutions, including data capture, eSource, and data management services. We bring more flexibility, better data quality, and greater efficiency to clinical trials everywhere in the world.
Twitter
Linkedin
Vimeo
Youtube
Twitter
Linkedin
Vimeo
Youtube

DFnet is a healthcare technology company that provides eClinical solutions, including electronic data capture, eSource, and data management services. We bring more flexibility, better data quality, and greater efficiency to clinical trials everywhere in the world.

2021 © DF/Net Research, Inc. All Rights Reserved

Company

  • About Us
  • Blog
  • Meet the team
  • Privacy Policy
  • Cookie Policy

Our Work

  • Solutions
  • Services
  • Industries
  • Resources

Stay in Touch

  • Contact Us
  • Schedule a Demo
  • Join the Community
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT

We use cookies

This website automatically uses the cookies needed to optimize your navigation. To allow additional cookies used to personalize content relevant to you, click “YES, I ACCEPT.”

Yes, I accept
Learn More